Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS1 | P09382 | 2/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.41 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.41 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.41 |
| ▸ | PYGB | P11216 | 3/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | FBP1 | P09467 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19250987 | 0.98 | LGALS1 (0.44) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL20686300 | 0.86 | LGALS1 (0.37) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL5833176 | 0.85 | ADORA3 (0.36) | FBP1ADORA3 | |
| SCHEMBL13063075 | 0.85 | LGALS1 (0.50) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL12295132 | 0.84 | LGALS1 (0.42) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL12909288 | 0.84 | LGALS1 (0.42) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL26448837 | 0.83 | CA2 (0.36) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL30610704 | 0.83 | CA2 (0.36) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL21250605 | 0.81 | CA2 (0.36) | LGALS1LGALS3LGALS9LGALS8PYGB | |
| SCHEMBL17517215 | 0.81 | CA2 (0.34) | PYGBFBP1ADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009158007-A2 | METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT | LIMERICK BIOPHARMA, INC. (US) | 2009-12-30 | — | — | WO | disclosed |